BioSpace News Archive

Susan G. Komen®, the world’s leading breast cancer organization, welcomed the results of the INFORM trial that were announced at the 2019 San Antonio Breast Cancer Symposium.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS), (“Marinus” or the “Company”) today announced the closing of an underwritten public offering of 32,200,000 shares of common stock at a public offering price of $1.25 per share, including the exercise in full by the underwriters of their option to purchase up to 4,200,000 additional shares of common stock

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019.

West Pharmaceutical Services, Inc. announced that the Company’s Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share.